+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Rabies Vaccines Market - Global Forecast 2026-2032- Product Image
Human Rabies Vaccines Market - Global Forecast 2026-2032- Product Image
New

Human Rabies Vaccines Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674553
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Rabies Vaccines Market is redefining clinical, regulatory, and supply strategies as health authorities and manufacturers respond to shifting global priorities and operational demands. This analysis is essential for decision-makers seeking to navigate rapid transformation in disease prevention and vaccine delivery.

Market Snapshot: Human Rabies Vaccines Market Overview

The Human Rabies Vaccines Market grew from USD 1.10 billion in 2025 to USD 1.15 billion in 2026 and is expected to continue expanding at a CAGR of 4.76%, reaching USD 1.52 billion by 2032. Market growth is being driven by evolving prophylaxis guidelines, enhanced manufacturing technologies, and increased health system investments worldwide.

Scope & Segmentation

  • Prophylaxis Types: Includes Pre Exposure Prophylaxis and Post Exposure Prophylaxis, each with distinct clinical protocols and deployment urgency.
  • Vaccine Classes: Covers Human Diploid Cell, Purified Chick Embryo Cell, and Purified Vero Cell vaccines with unique production and immunogenic profiles.
  • Routes of Administration: Details Intradermal and Intramuscular techniques, highlighting dose-sparing opportunities and clinical familiarity.
  • Formulation Types: Addresses Liquid and Lyophilized variants, factoring in cold-chain and on-site handling needs.
  • End Users: Segments the market by Clinics, Hospitals, and Research Institutes, affecting demand patterns and compliance processes.
  • Distribution Channels: Includes Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies, linking procurement methods with patient access and oversight.
  • Geographic Regions: Explores dynamics in Americas, EMEA, and Asia-Pacific, reflecting diverse public health infrastructures, regulatory sophistication, and manufacturing capabilities.
  • Technological Innovations: Examines scalable cell-culture platforms, single-use bioprocessing, cold-chain optimization, and digital integration for supply visibility.

Key Takeaways for Senior Decision-Makers

  • Technological innovation is progressing, with manufacturers moving toward cell-culture systems for greater efficiency and operational consistency.
  • Regulatory harmonization is streamlining approval processes, supporting technology transfer and regional manufacturing flexibility.
  • Operational redesigns are integrating rabies vaccine delivery within broader control programs, relying on new distribution models and hybrid outreach strategies.
  • Segmented approaches tailored to prophylaxis type, formulation, and end user optimize inventory management, protocol training, and resource allocation.
  • Cross-regional strategies reflect unique supply chain, regulatory, and outreach realities; adaptability is crucial in procurement and program design.
  • Industry differentiation increasingly rests on added-value services such as predictive analytics, cold-chain monitoring, and clinical training rather than novel formulations alone.

Tariff Impact and Supply Chain Resilience

Recent trade policy shifts—particularly tariffs implemented in 2025—intensified risks across vaccine supply chains. These changes affected procurement processes, cost structures, and supplier selection, prompting a strategic reassessment of sourcing, inventory, and manufacturing locations. Manufacturers responded by accelerating local production, diversifying suppliers, and managing capital tied up in safety stocks. Contract terms now focus on supplier resilience and price stability, reinforcing the importance of scenario planning and robust risk management for continuous vaccine access.

Methodology & Data Sources

This report synthesizes insights from structured primary interviews with clinical, regulatory, and supply chain experts, validated against authoritative regulatory, scientific, and industry literature. Methodological triangulation and sensitivity analysis enhance reliability, ensuring that operational, clinical, and procurement trends are reflected accurately.

Why This Report Matters

  • Empowers health system leaders with strategic frameworks for supply resilience, clinical optimization, and digital supply chain management.
  • Delivers actionable analysis for investment and procurement teams seeking to assess risk, regulatory alignment, and market positioning.
  • Helps manufacturers and partners identify technological and regional differentiators driving competitive advantage in vaccine production and delivery.

Conclusion

The Human Rabies Vaccines Market is entering a new era shaped by technological, regulatory, and supply chain adaptation. Strategic insight and agile decision-making are essential for stakeholders committed to expanding and sustaining prophylactic coverage under evolving regulatory and market conditions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Human Rabies Vaccines Market, by Vaccine Type
8.1. Post Exposure Prophylaxis
8.2. Pre Exposure Prophylaxis
9. Human Rabies Vaccines Market, by Vaccine Class
9.1. Human Diploid Cell
9.2. Purified Chick Embryo Cell
9.3. Purified Vero Cell
10. Human Rabies Vaccines Market, by Route Of Administration
10.1. Intradermal
10.2. Intramuscular
11. Human Rabies Vaccines Market, by Formulation
11.1. Liquid
11.2. Lyophilized
12. Human Rabies Vaccines Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Online Pharmacies
12.3. Retail Pharmacies
13. Human Rabies Vaccines Market, by End User
13.1. Clinics
13.2. Hospitals
13.3. Research Institutes
14. Human Rabies Vaccines Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Human Rabies Vaccines Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Human Rabies Vaccines Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Human Rabies Vaccines Market
18. China Human Rabies Vaccines Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Bavarian Nordic A/S
19.6. Beijing Minhai Biotechnology Co., Ltd.
19.7. Bharat Biotech International Limited
19.8. Bio-Med Pvt. Ltd.
19.9. Cadila Healthcare Ltd.
19.10. Changchun Institute of Biological Products Co., Ltd.
19.11. Chengda Biotechnology Co., Ltd.
19.12. China National Pharmaceutical Group Co., Ltd.
19.13. GlaxoSmithKline plc
19.14. Hualan Biological Engineering Inc.
19.15. Indian Immunologicals Limited
19.16. Medigen Biotechnology Corporation
19.17. Merck & Co., Inc.
19.18. Novartis AG
19.19. PT Bio Farma (Persero) Tbk
19.20. Sanofi SA
19.21. Serum Institute of India Pvt. Ltd.
19.22. Shenzhen Kangtai Biological Products Co., Ltd.
19.23. Sinovac Biotech Ltd.
19.24. Valneva SE
List of Figures
FIGURE 1. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HUMAN RABIES VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HUMAN RABIES VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA HUMAN RABIES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY POST EXPOSURE PROPHYLAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PRE EXPOSURE PROPHYLAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HUMAN DIPLOID CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HUMAN DIPLOID CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HUMAN DIPLOID CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED CHICK EMBRYO CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED CHICK EMBRYO CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED CHICK EMBRYO CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED VERO CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED VERO CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY PURIFIED VERO CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRADERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRADERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LYOPHILIZED, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LYOPHILIZED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY LYOPHILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 85. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 87. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. EUROPE HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 98. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 99. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 100. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 101. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. AFRICA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 114. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 115. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 116. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. ASEAN HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. GCC HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GCC HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 120. GCC HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 121. GCC HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 122. GCC HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 123. GCC HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. GCC HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 134. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 135. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 137. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. BRICS HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. G7 HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. G7 HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 141. G7 HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 142. G7 HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 143. G7 HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 144. G7 HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. G7 HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. NATO HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. NATO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 148. NATO HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 149. NATO HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. NATO HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 151. NATO HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. NATO HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL HUMAN RABIES VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. CHINA HUMAN RABIES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 162. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2032 (USD MILLION)
TABLE 163. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY VACCINE CLASS, 2018-2032 (USD MILLION)
TABLE 164. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 166. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. CHINA HUMAN RABIES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Human Rabies Vaccines market report include:
  • Bavarian Nordic A/S
  • Beijing Minhai Biotechnology Co., Ltd.
  • Bharat Biotech International Limited
  • Bio-Med Pvt. Ltd.
  • Cadila Healthcare Ltd.
  • Changchun Institute of Biological Products Co., Ltd.
  • Chengda Biotechnology Co., Ltd.
  • China National Pharmaceutical Group Co., Ltd.
  • GlaxoSmithKline plc
  • Hualan Biological Engineering Inc.
  • Indian Immunologicals Limited
  • Medigen Biotechnology Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • PT Bio Farma (Persero) Tbk
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co., Ltd.
  • Sinovac Biotech Ltd.
  • Valneva SE

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.15 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.52 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Chick Embryo Cell Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Chick Embryo Cell Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Human Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030 - Product Image

Human Rabies Vaccine Antibody Testing Service Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Rabies Vaccine Market - Global Strategic Business Report - Product Image

Rabies Vaccine Market - Global Strategic Business Report

  • Report
  • 467 Pages
  • Global
From
Rabies Vaccines for Animals Market - Global Forecast 2025-2030 - Product Image

Rabies Vaccines for Animals Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Rabies Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Rabies Vaccine Market

The Rabies Vaccine market is a subset of the Vaccines market, which is a global industry that produces and distributes immunizations to protect against infectious diseases. Rabies Vaccines are used to protect against the rabies virus, which is a fatal disease that is spread through the saliva of infected animals. The Rabies Vaccine market is composed of a variety of products, including pre-exposure and post-exposure vaccines, as well as combination vaccines. These products are used in both humans and animals, and are typically administered by injection. The Rabies Vaccine market is highly regulated, with stringent safety and efficacy standards in place to ensure the quality of the products. Additionally, the market is subject to a variety of government regulations, including those related to pricing and distribution. Some companies in the Rabies Vaccine market include Merck & Co., Inc., Sanofi Pasteur, GlaxoSmithKline, and Pfizer, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.